Editorial: Hepatic insulin resistance and related obesity: highlighting the ameliorative role of nutraceuticals, dietary intervention, and pharmaceuticals

• Nehal M. Ramadan,
• Priscila O. Barbosa,
• Nada F. Abo El-Magd,
• Salma M. Eraky,
• Mohammed M. H. Al-Gayyar,
• Mohammed M. H. Al-Gayyar

Affiliations

Nehal M. Ramadan

Clinical Pharmacology Department, Faculty of Medicine, Mansoura University, Mansoura, Egypt

Priscila O. Barbosa

Centre for Obesity Research and Education (CORE), School of Pharmacy and Life Sciences, Robert Gordon University, Aberdeen, United Kingdom

Nada F. Abo El-Magd

Department of Biochemistry, Faculty of Pharmacy, Mansoura University, Mansoura, Egypt

Salma M. Eraky

Department of Biochemistry, Faculty of Pharmacy, Mansoura University, Mansoura, Egypt

Mohammed M. H. Al-Gayyar

Department of Biochemistry, Faculty of Pharmacy, Mansoura University, Mansoura, Egypt

Mohammed M. H. Al-Gayyar

Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Tabuk, Tabuk, Saudi Arabia